SunTrust initiates coverage on Fresenius Medical Care AG (FMS) with a Buy
More News related to FMS
- Fresenius Medical Care North America Acquires Health IT Services Group, Acumen nEHR
- Fresenius Med ADS (FMS) Posts Q3 EPS of $0.76, Tops Street by 1c; Guides
- Fresenius Medical Care Reports Strong Third Quarter and Nine Months Results; Improved Guidance for 2009
- Trading Overview for MedaSorb Technologies Corp. Issued by StockPreacher.com
- Don't Miss Out! Two Weeks Left to Register for the 2010 IR Global Rankings
SunTrust initiates coverage on Fresenius Medical Care AG (NYSE: FMS) with a Buy. Price target $51.
Fresenius Medical Care AG & Co. KGaA (FMC-AG & Co. KGaA), is a kidney dialysis company, operating in both the field of dialysis products and the field of dialysis services.
Related Categories
New CoverageStocks Mentioned
-0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
